Regarding the latter, HIF2α‐dependent effects in the liver appear to be linked to its activation level, thus mild HIF2α activation will enhance insulin signalling and fatty acid oxidation whereas potent HIF2α activation will lead to liver dysfunction and steatosis.33 The gene discussed is EPAS1; the disease is steatosis.